Delivery Order SPE2DB20D3103-SPE2DB25FQ4L7
- Not listed
- The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 2% Viscous Solution 100ML under a firm fixed-price contract valued at $6,361.57. The contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $8,737.98 to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,564,298,127 units of Lidocaine 2% Viscous Solution in 100 mL containers. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of the pharmaceutical...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution 4ML on June 10, 2025, with a ceiling value of $1,209.14 and ultimate completion date of June 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a delivery order valued at $8,087.53 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 200 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,123.68, is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $369.37 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 100ml bottles of 2% viscous lidocaine solution. The firm fixed price order is for product delivery from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by August 14, 2023. No major subcontractors or set aside designations were identified. As a leading provider of pharmaceuticals and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.27, is for the delivery of 4564203887 - Lidocaine 2% Viscous 15 ML Cup UD 15ML. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4L7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lidocaine 2% Viscous in 15 mL unit dose cups. The contract, valued at $3,828.36 with a firm fixed price structure, was competitively awarded without set-aside provisions and is scheduled for completion by September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle that runs through December 2026 and serves as the primary mechanism for supplying pharmaceuticals and medical supplies to military healthcare systems worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a vendor for the Defense Health Agency and other government healthcare systems. The company's federal awards consistently involve competitively awarded delivery orders for a diverse range of pharmaceutical products, from small-value transactions to orders exceeding $45,000. The Lidocaine supply contract reflects the company's ongoing support of military medical operations and aligns with the Defense Logistics Agency's broader pharmaceutical procurement strategy under the Troop Support Medical contract, which encompasses specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/23/25 |